Читать книгу The Peripheral T-Cell Lymphomas - Группа авторов - Страница 59

As shared in other chapters, there are a number of new drugs that target the PTCL epigenome which have been approved by various regulatory agencies around the world. A summary of these data is provided in Table 3.2. In addition to the approved agents, there are a number of promising single‐agent drugs that target the epigenome in unique fashion, which may play an important role, alone or in combination, in the treatment of T‐cell malignancies. A review of these novel agents is shared below.